Related references
Note: Only part of the references are listed.KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy
Tawfeeq Shekh-Ahmad et al.
BRAIN (2018)
Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds
Piul S. Rabbani et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
Albena T. Dinkova-Kostova et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2017)
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors
Ben C. Creelan et al.
ONCOTARGETS AND THERAPY (2017)
Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates
Fernando Bartolome et al.
SCIENTIFIC REPORTS (2017)
Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function
Noemi Esteras et al.
BIOLOGICAL CHEMISTRY (2016)
'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'
R. Abeti et al.
CELL DEATH & DISEASE (2016)
The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergetics
Albena T. Dinkova-Kostova et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia
Rosella Abeti et al.
PHARMACOLOGICAL RESEARCH (2015)
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
Brandon L. Probst et al.
PLOS ONE (2015)
Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers
Scott A. Reisman et al.
BMC DERMATOLOGY (2015)
Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin
Scott A. Reisman et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
Tongde Wu et al.
GENES & DEVELOPMENT (2014)
Mitochondrial reactive oxygen species production and elimination
Alexander Nickel et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis
Scott A. Reisman et al.
RADIATION RESEARCH (2014)
Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation
Alain Martelli et al.
FRONTIERS IN PHARMACOLOGY (2014)
Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model
Yuxi Shan et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Clinical features of Friedreich's ataxia: classical and atypical phenotypes
Michael H. Parkinson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death
Rosella Abeti et al.
BRAIN (2011)
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin
Ivano Condo et al.
HUMAN MOLECULAR GENETICS (2010)
PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia
Daniele Marmolino et al.
PLOS ONE (2010)
Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia
Vincent Paupe et al.
PLOS ONE (2009)
Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy
J. M. Cooper et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Friedreich's ataxia:: Coenzyme Q10 and vitamin E therapy
J. M. Cooper et al.
MITOCHONDRION (2007)
GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology
Sahar Al-Mahdawi et al.
GENOMICS (2006)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1)
E Lesuisse et al.
HUMAN MOLECULAR GENETICS (2003)
Share Paper
